Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Pediatric Blood & Cancer
|
January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study
Lars M Wagner, John P Perentesis, Joel M Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors
Lars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Cancer Research
|
September 5, 2002
Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients
Lars M Wagner, Sylvie M Guichard, Rebecca A Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2013
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group
Robert E Goldsby, Timothy M Fan, Doojduen Villaluna, et al.
Pediatric Blood & Cancer
|
May 10, 2020
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation
Javier E Oesterheld, Damon R Reed, Bhuvana A Setty, et al.
Pediatric Blood & Cancer
|
September 15, 2017
Consensus and controversies regarding the treatment of rhabdomyosarcoma
Scott C Borinstein, Diana Steppan, Masanori Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2011
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study
Maryam Fouladi, Clinton F Stewart, James Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study
Lars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Maryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 15, 2007
Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials
Elke Will, Jeff Bailey, Todd Schuesler, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Pediatric Blood & Cancer
|
January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study
Lars M Wagner, John P Perentesis, Joel M Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors
Lars M Wagner, Kristine R Crews, Lisa C Iacono, et al.
Cancer Research
|
September 5, 2002
Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients
Lars M Wagner, Sylvie M Guichard, Rebecca A Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2013
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group
Robert E Goldsby, Timothy M Fan, Doojduen Villaluna, et al.
Pediatric Blood & Cancer
|
May 10, 2020
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation
Javier E Oesterheld, Damon R Reed, Bhuvana A Setty, et al.
Pediatric Blood & Cancer
|
September 15, 2017
Consensus and controversies regarding the treatment of rhabdomyosarcoma
Scott C Borinstein, Diana Steppan, Masanori Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2011
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study
Maryam Fouladi, Clinton F Stewart, James Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study
Lars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Maryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 15, 2007
Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials
Elke Will, Jeff Bailey, Todd Schuesler, et al.
Page
of 5